170 related articles for article (PubMed ID: 8386064)
1. Enhancement of coxsackievirus B3 myocarditis in mice by lobenzarit disodium through inhibition of splenic pan T cells.
Kishimoto C; Takada H; Kuroki Y; Matsushita I; Hiraoka Y; Kurokawa M; Ochiai H; Sasayama S
Cardiovasc Res; 1993 Feb; 27(2):243-8. PubMed ID: 8386064
[TBL] [Abstract][Full Text] [Related]
2. The effects of lobenzarit disodium, a novel immunomodulator, upon murine coxsackievirus B3 myocarditis.
Takada H; Kishimoto C; Kuroki Y; Matsushita I; Hiraoka Y; Kurokawa M; Ochiai H; Sasayama S
Heart Vessels; 1993; 8(2):59-66. PubMed ID: 8390975
[TBL] [Abstract][Full Text] [Related]
3. Absence of effects of cyclosporine on myocardial lymphocyte subsets in Coxsackievirus B3 myocarditis in the aviremic stage.
Kishimoto C; Abelmann WH
Circ Res; 1989 Oct; 65(4):934-45. PubMed ID: 2551533
[TBL] [Abstract][Full Text] [Related]
4. Serial immunologic identification of lymphocyte subsets in murine coxsackievirus B3 myocarditis: different kinetics and significance of lymphocyte subsets in the heart and in peripheral blood.
Kishimoto C; Misaki T; Crumpacker CS; Abelmann WH
Circulation; 1988 Mar; 77(3):645-53. PubMed ID: 2830046
[TBL] [Abstract][Full Text] [Related]
5. Cytokine and murine coxsackievirus B3 myocarditis. Interleukin-2 suppressed myocarditis in the acute stage but enhanced the condition in the subsequent stage.
Kishimoto C; Kuroki Y; Hiraoka Y; Ochiai H; Kurokawa M; Sasayama S
Circulation; 1994 Jun; 89(6):2836-42. PubMed ID: 8205699
[TBL] [Abstract][Full Text] [Related]
6. The effects of FK-506, a novel and potent immunosuppressant, upon murine Coxsackievirus B3 myocarditis.
Hiraoka Y; Kishimoto C; Kurokawa M; Ochiai H; Sasayama S
J Pharmacol Exp Ther; 1992 Mar; 260(3):1386-91. PubMed ID: 1372051
[TBL] [Abstract][Full Text] [Related]
7. Effects of polyethylene glycol conjugated superoxide dismutase on coxsackievirus B3 myocarditis in mice.
Hiraoka Y; Kishimoto C; Kurokawa M; Ochiai H; Sasayama S
Cardiovasc Res; 1992 Oct; 26(10):956-61. PubMed ID: 1336713
[TBL] [Abstract][Full Text] [Related]
8. Effects of granulocyte colony-stimulating factor upon coxsackievirus B3 myocarditis in mice.
Hiraoka Y; Kishimoto C; Takada H; Suzaki N; Shiraki K
Eur Heart J; 1995 Dec; 16(12):1900-6. PubMed ID: 8682024
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppression with high doses of cyclophosphamide reduces the severity of myocarditis but increases the mortality in murine Coxsackievirus B3 myocarditis.
Kishimoto C; Thorp KA; Abelmann WH
Circulation; 1990 Sep; 82(3):982-9. PubMed ID: 2168299
[TBL] [Abstract][Full Text] [Related]
10. Effects of naloxone, an opiate receptor antagonist, on coxsackievirus B3 myocarditis in the mouse.
Kishimoto C; Takada H; Hiraoka Y; Shiraki K
Cardiovasc Res; 1995 Jan; 29(1):80-4. PubMed ID: 7895243
[TBL] [Abstract][Full Text] [Related]
11. Immunological mechanisms in experimental coxsackievirus B3 myocarditis in mice.
Kishimoto C; Ochiai H; Sasayama S
Jpn Circ J; 1991 Nov; 55(11):1144-8. PubMed ID: 1721094
[TBL] [Abstract][Full Text] [Related]
12. Ribavirin treatment of murine coxsackievirus B3 myocarditis with analyses of lymphocyte subsets.
Kishimoto C; Crumpacker CS; Abelmann WH
J Am Coll Cardiol; 1988 Nov; 12(5):1334-41. PubMed ID: 2844874
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of recombinant alpha interferon on coxsackievirus B3 myocarditis in mice.
Matsumori A; Tomioka N; Kawai C
Am Heart J; 1988 Jun; 115(6):1229-32. PubMed ID: 2837073
[TBL] [Abstract][Full Text] [Related]
14. Role of oxygen derived free radicals in the pathogenesis of coxsackievirus B3 myocarditis in mice.
Hiraoka Y; Kishimoto C; Takada H; Kurokawa M; Ochiai H; Shiraki K; Sasayama S
Cardiovasc Res; 1993 Jun; 27(6):957-61. PubMed ID: 8221785
[TBL] [Abstract][Full Text] [Related]
15. In vivo significance of T cells in the development of Coxsackievirus B3 myocarditis in mice. Immature but antigen-specific T cells aggravate cardiac injury.
Kishimoto C; Abelmann WH
Circ Res; 1990 Sep; 67(3):589-98. PubMed ID: 1697791
[TBL] [Abstract][Full Text] [Related]
16. Prevention of murine coxsackie B3 viral myocarditis and associated lymphoid organ atrophy with recombinant human leucocyte interferon alpha A/D.
Kishimoto C; Crumpacker CS; Abelmann WH
Cardiovasc Res; 1988 Oct; 22(10):732-8. PubMed ID: 2855719
[TBL] [Abstract][Full Text] [Related]
17. Cell-mediated immune cardiocyte injury in viral myocarditis of mice and patients.
Deguchi H; Kitaura Y; Hayashi T; Kotaka M; Kawamura K
Jpn Circ J; 1989 Jan; 53(1):61-77. PubMed ID: 2541265
[TBL] [Abstract][Full Text] [Related]
18. The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis.
Henke A; Huber S; Stelzner A; Whitton JL
J Virol; 1995 Nov; 69(11):6720-8. PubMed ID: 7474082
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibody therapy for prevention of acute coxsackievirus B3 myocarditis in mice.
Kishimoto C; Abelmann WH
Circulation; 1989 Jun; 79(6):1300-8. PubMed ID: 2541943
[TBL] [Abstract][Full Text] [Related]
20. Lymphokine activated killer cells in murine coxsackievirus B3 myocarditis.
Kishimoto C; Kuroki Y; Kurokawa M; Ohiai H
Basic Res Cardiol; 1997 Dec; 92(6):402-9. PubMed ID: 9464864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]